Expert Video - Who is at risk of treatment failure and relapse in AML?
Acute myeloid leukemia (AML) expert Dr. Barry Skikne explains that any person with AML is at risk for treatment failure and relapse in AML, however older persons tend to have an increased risk. In people over 60, treatment failure may be close to 50 percent. Patients can be stratified into low, intermediate, or poor risk disease based on the characteristics of their leukemia, and this stratification can help determine risk of treatment failure.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.